SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist
SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist is a paper indexed in ScholarIQ from OpenAlex.
How many citations does SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist have?
SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist has 10 citations in the OpenAlex counts ScholarIQ stores.
When was SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist published?
SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist has 2022 year in the ScholarIQ index.
What is the open-access status of SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist?
SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist has gold oa status in the ScholarIQ index.
What is the DOI of SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist?
The DOI for SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist is on the source record.
What is the PMID of SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist?
The PMID for SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist is on the source record.
What is the OpenAlex record for SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist?
The OpenAlex for SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist is on the source record.